Summary

The STAR Trial of TAVR with MiRus Siegel is launching in early April 2026, marking the first patients enrolled in a major clinical investigation testing the new transcatheter heart valve. This groundbreaking study will examine the efficacy and safety of a specific surgical valve design in a controlled group of patients to determine if it offers superior outcomes compared to traditional options. The researchers aim to identify critical factors influencing patient success and identify potential safety risks associated with this new technology. Medical professionals worldwide are preparing to utilize this pioneering research, which is set to revolutionize how heart valves are implanted during major surgeries in the coming year.

Title

Cardiac Interventions Today

Description

News and information on minimally invasive coronary disease therapies, covering valvular, structural, radial access, chronic total occlusion, and imaging issues.

Keywords

april, news, device, cardiology, trial, imaging, sketch, guide, coronary, coding, interventions, issue, radial, advertisement, view, system, risk

NS Lookup

A 3.222.127.84, A 100.49.122.111

Dates

Created 2026-04-14

Updated 2026-04-15

Summarized 2026-04-15